Ovarian Neoplasms: all 2,757 studies
Page 3 of 28. Open to participants first (735), then studies with results posted, then the rest; newest registration first within each.
- Secondary Cytoreductive Surgery After Chemotherapy for Recurrent Epithelial Ovarian CancerRecruitingNCT07171528Phase 2
- Identifying Genetic Targets in Gynecological TumorsRecruitingNCT07169396
- Efficacy and Safety of Sacituzumab in Patients With OCCC After Immunotherapy ProgressionNot yet recruitingNCT07168083
- Clinical Validation of Sophia Genetics AssayNot yet recruitingNCT07160010
- Study of SYN818 With Olaparib for the Treatment of Locally Advanced or Metastatic Solid TumorsRecruitingNCT07156253Phase 1
- OCS Products Based on Exosome Technology Were Applied in the Recurrence Monitoring Study After the Initial Treatment of Baseline CA125-negative Ovarian CancerNot yet recruitingNCT07153705
- Effects of a Probiotic Intervention on the Gut and Vaginal Microbiome in Patients With Advanced or Recurrent Ovarian Cancer Undergoing Treatment With Platinum ChemotherapyRecruitingNCT07144826Early Phase 1
- Chemotherapy Combined With Propranolol Hydrochloride as Neoadjuvant Therapy for Advanced High-grade Serous Ovarian CancerRecruitingNCT07125391Phase 2
- Cognitive Impact of Neoadjuvant Chemotherapy for Gynecologic CancersRecruitingNCT07125209
- DESTINY-PANTUMOUR04RecruitingNCT07124000
- Etoposide Capsules Combined With Bevacizumab and Iparomlimab and Tuvonralimab in the Treatment of Platinum Resistant or Platinum Refractory Ovarian CancerNot yet recruitingNCT07117877Phase 2
- A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway AlterationsRecruitingNCT07109726Phase 1/2
- Anatomopathological Analysis of the Infundibulopelvic Ligament in Patients With Ovarian CancerRecruitingNCT07100288
- Contribution of Preserving the Superior Left Colic Artery to the Vascularization of the Descending Colon Prior to Colorectal Anastomosis During Left-Sided or Rectal Resections for Colorectal or Ovarian Cancer. (Revascularisation Colique)RecruitingNCT07098182Not applicable
- PITCH - Impacting Hereditary Cancer TestingNot yet recruitingNCT07090109Not applicable
- Study of SYN608 for the Treatment of Advanced or Metastatic Solid TumorsNot yet recruitingNCT07088588Phase 1
- Multimedia Aid for Genetic Testing in Gynecologic OncologyRecruitingNCT07084168Not applicable
- Clinician Nudge to Referral of Adnexal Masses to Gynecologic OncologyEnrolling by invitationNCT07078409Not applicable
- Centralization and Oncologic Outcomes in Ovarian CancerRecruitingNCT07075939
- Proactive Hemodynamic Management During Cytoreductive Surgery and HIPECRecruitingNCT07070973Not applicable
- UNTOLD Ovarian Cancer Unmet Needs SurveyRecruitingNCT07070726
- A Bioequivalence Study to Evaluate Pharmacokinetics and Safety of BR2022 and BR2022-1 in Patients With Deleterious or Suspected Deleterious Germline BRCA-Mutated Advanced Ovarian CancerRecruitingNCT07069335Phase 1
- ICRA Randomised Controlled TrialNot yet recruitingNCT07068464Phase 3
- Sequential CD146 and GPC3 CAR-T Cell Therapy in Advanced Ovarian CancerRecruitingNCT07067255Phase 1/2
- Trial of Single Protein Encapsulated Doxorubicin, SPEDOX-6 in Advanced MalignanciesRecruitingNCT07064018Phase 1/2
- Distance-Based Exercise to Preserve Function and Prevent DisabilityRecruitingNCT07059884Not applicable
- A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian CancerRecruitingNCT07059845Phase 2
- Prehabilitation in Ovarian Cancer Patients During Chemiotherapy Before Cytoreductive Surgery.Enrolling by invitationNCT07058753Not applicable
- Prediction of Ovarian Cancer Histotypes and Surgical OutcomeNot yet recruitingNCT07057167
- Comprehensive Multimodal Prehabilitation Alone or With Neoadjuvant Therapy Before Major Cancer SurgeryRecruitingNCT07050771Phase 2
- Phase II Clinical Study of Utidelone Capsule (UTD2) in Patients With Advanced Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal CancerNot yet recruitingNCT07044349Phase 2
- A Study of LBL-024 in Combination With Paclitaxel ± Bevacizumab for the Treatment of Platinum-resistant Ovarian CancerRecruitingNCT07042802Phase 1/2
- Short-term Fasting Compared to Free Diet on Ovarian Cancer PatientsRecruitingNCT07039331Not applicable
- Diagnosis of Multiple Cancer and Monitoring of Minimal Residual Tumors After Treatment Using Blood and High-Sensitivity Genetic Analysis TechniquesRecruitingNCT07035587
- Neoadjuvant Treatment of Ovarian Cancer With Fuzuloparib in Combination With ApatinibRecruitingNCT07033819Phase 2
- Minimally Invasive Interval Debulking Surgery in Advanced Ovarian CancerNot yet recruitingNCT07031908
- A Study to Evaluate the Safety and Efficacy of OPB-101 in Platinum-resistant Ovarian CancerRecruitingNCT07030907Phase 1
- Ultrasound Training Program for Gynecologic Cancer Staging in ResidentsNot yet recruitingNCT07028229Not applicable
- A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 OverexpressionRecruitingNCT07023627Phase 2
- Personalized Timing of Interval Debulking Surgery in Advanced Ovarian CancerRecruitingNCT07023484Phase 2
- Personalised Timing of Interval Debulking Surgery in Advanced Ovarian CancerRecruitingNCT07022535Phase 2
- A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory CarcinomasRecruitingNCT06999187Phase 1
- The Vanguard Study: Testing a New Way to Screen for CancerRecruitingNCT06995898Not applicable
- Phase 1/2 Study of ETX-636 in Participants With Advanced Solid TumorsRecruitingNCT06993844Phase 1/2
- SHR - A1811 Injection in the Treatment of Platinum-sensitive Recurrent Ovarian CancerNot yet recruitingNCT06990516Phase 1/2
- SHR - A1811 Versus Chemotherapy for Platinum-resistant Recurrent Epithelial Ovarian CancerNot yet recruitingNCT06990503Phase 3
- Ultrasound-guided Transvaginal Aspiration of Cystic Pelvic LesionsRecruitingNCT06988280
- Total Neoadjuvant 6 Cycles of Chemotherapy Versus 3 Cycles in Partial Responder Patients Diagnosed With Epithelial Ovarian CancerNot yet recruitingNCT06980545Phase 3
- Proactive Immune Tolerance Induction in Chemotherapy for Gynecologic CancerRecruitingNCT06977594Not applicable
- Investigating Idetrexed and Olaparib in Patients With Ovarian CancerRecruitingNCT06976892Phase 1
- Phase II Study of Utidelone Plus Fruquintinib Combination Therapy for Platinum-Resistant Recurrent Ovarian CancerNot yet recruitingNCT06973421Phase 2
- Autophagy Maintenance (AUTOMAIN)RecruitingNCT06971744Phase 2
- Prospective Clinico-biological Database of Patients With Ovarian and/or Peritoneal and/or Fallopian Tube CarcinomaRecruitingNCT06969833Not applicable
- DT2216 + Paclitaxel in Platinum-Resistant Ovarian CancerRecruitingNCT06964009Phase 1
- Validation of the Sentinel Lymph Node Technique in Early-stage Ovarian Cancer (SENTOV II)RecruitingNCT06963268Phase 3
- Healthy Volunteers StudyRecruitingNCT06962059
- Fluzoparib+Bevacizumab/Dietary Intervention vs Fluzoparib Monotherapy as First-line Maintenance in HRD+/- Advanced Ovarian CancerRecruitingNCT06954584Phase 3
- DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid TumorsRecruitingNCT06953089Phase 2
- A Study of MT-4561 in Patients With Various Advanced Solid TumorsRecruitingNCT06943521Phase 1/2
- Evaluation of Polygenic Risk Score for Epithelial OVarian cancEr Risk Prediction: the PROVE StudyRecruitingNCT06935344
- Study of NMS-03305293 in Adult Patients With Relapsed Ovarian CancerRecruitingNCT06930755Phase 1
- Early Phase Study of KESONOTIDE™in Participants With Solid TumoursRecruitingNCT06926075Phase 1/2
- Exosome-based Recurrence Score for Post-Treatment Ovarian CancerNot yet recruitingNCT06925126
- Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal CancerRecruitingNCT06915025Phase 3
- Patient Centered Clinical Decision Support for Hereditary Cancer SyndromesEnrolling by invitationNCT06914726Not applicable
- IDOV-Immune for Advanced Solid TumorsRecruitingNCT06910657Phase 1
- Study of the Impact on Survival of a Paradigm Shift in the Therapeutic Strategy of Patients With Advanced Ovarian CancerRecruitingNCT06907771
- Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological CancersRecruitingNCT06906341Phase 2
- Combined Intraperitoneal Chemotherapy Regimen After Optimal Interval Surgery in Advanced Ovarian Cancer: BICOV-1 (Bidirectional Chemotherapy in Ovarian Cancer)RecruitingNCT06902467Not applicable
- A Clinical Study on Fasudil Hydrochloride for Treatment of Gene-Specific Ovarian CancerRecruitingNCT06890858Phase 2
- A Trial to Evaluate the Safety of Niraparib Tablets in Adult Female Participants With Advanced or Relapsed Epithelial Ovarian CancerNot yet recruitingNCT06887933Phase 4
- Lipid Mediators & Cancer: Montelukast, SPM, and AlmondsNot yet recruitingNCT06887673Early Phase 1
- Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including MesotheliomaRecruitingNCT06885697Phase 1
- A Long-Term Follow-Up Study of Participants Treated With A2 Biotherapeutics (A2 Bio) Gene Therapy (GT) ProductsEnrolling by invitationNCT06885424
- Laparoscopic Interval Cytoreductive Surgery in Advance Ovarian CancerRecruitingNCT06883409Not applicable
- Retrospective Evaluation of Minimally-Invasive Surgical Strategies in Ovarian Neoplasms (REMISSION Study)RecruitingNCT06879730
- A Study of DC05F01 in Chinese Patients With Recurrent/Refractory Ovarian Cancer and Other Advanced Solid TumorsRecruitingNCT06873555Phase 1/2
- Paclitaxel Lipid Suspension for Patients with Platinum-Resistant /Refractory Ovarian CancerNot yet recruitingNCT06867562Phase 3
- An Automated Personalized Physical Activity Intervention to Improve Immune Function and Clinical Outcomes in Stage II-IV Ovarian, Primary Peritoneal or Fallopian Tube Cancer and Newly Diagnosed Endometrial Cancer, Life on the Go 3 StudyRecruitingNCT06855706Not applicable
- HS-20089 for Injection in Patients With Platinum-Resistant Recurrent Epithelial Ovarian CancerRecruitingNCT06855069Phase 3
- Trop2-targeted immunoPET Imaging of Solid TumorsRecruitingNCT06851663Phase 2/3
- Ovarian Cancer Identification on CT Using Deep LearningRecruitingNCT06851429
- SCT-001 CAR T Cells Therapy for Relapsed and Refractory Ovarian CancerNot yet recruitingNCT06846424Phase 1
- ChemoINTEL Assay Algorithm Development Study: In-Vitro Cytotoxic Drug Induced Apoptosis Correlation with Patient Clinical Response to Administered Chemotherapy in PatientsRecruitingNCT06844136
- Clinical Application of PET Imaging Targeting MSLN in Malignant TumorsRecruitingNCT06843629
- A Study of PHST001 in Advanced Solid TumorsRecruitingNCT06840886Phase 1
- A Clinical Study of SHR-A1811 Combined With Chemotherapy for Platinum Sensitive Recurrent Ovarian CancerRecruitingNCT06840002Phase 1/2
- Inhibiting Beta-adrenergic and COX-2 Signaling During the Perioperative Period to Reduce Ovarian Cancer ProgressionRecruitingNCT06839144Phase 2
- PARPi and Ovarian Cancer SurvivalNot yet recruitingNCT06838429
- Measure of Outcomes in Patients With Advanced Ovarian Cancer According to Homologous Recombination Status and Matched Therapies in a Real-world ScenarioRecruitingNCT06836219
- A Study of SHR-A1811 in Subjects With Ovarian CancerRecruitingNCT06828354Phase 3
- Niraparib Versus Bevacizumab As Maintenance Therapy in Patients with De Novo Ovarian Cancer Without Homologous Recombination DeficiencyRecruitingNCT06827353
- A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)RecruitingNCT06824467Phase 3
- Phase I/II Clinical Study to Evaluate VB15010 Tablets in Patients With Advanced Solid TumorsRecruitingNCT06819215Phase 1/2
- Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)RecruitingNCT06819007Phase 3
- Ovarian Cancer Radiomics Approach in CT Led EvaluationRecruitingNCT06817174
- Benefit of Transcutaneous Auricular Vagus Nerve Stimulation in Improving Quality of Life in First Line Treatment of Ovarian Cancer:RecruitingNCT06817161Phase 3
- Telmisartan in Combination With Cytotoxic Regimens in Platinum-Resistant Ovarian CancerRecruitingNCT06815497Phase 2
- ACT-Based Nursing Intervention for Ovarian Cancer Patients: A Pilot StudyNot yet recruitingNCT06813001Not applicable
- Evaluating Efficacy and Tolerability of Anticancer Drug Therapies for the Treatment of Gynecologic and Breast CancersRecruitingNCT06800612